C&R Research Services USA

Houston, Texas 77023

0 studies enrolling now · 6 studies all time

What they study most

COVID-19, Covid19, Cytokine Release Syndrome, Lyme Disease, SARS-CoV-2 Infection

Studies at this site

• Safety Study of a Vaccine to Help Protect Against Lyme Disease in Healthy Children — Completed
• Phase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 Infection — Completed
• EPIC-HR: Study of Oral PF-07321332/Ritonavir Compared With Placebo in Nonhospitalized High Risk Adults With COVID-19 — Completed
• Bucillamine in Treatment of Patients With COVID-19 — Stopped early
• A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection — Completed
• Safety and Efficacy of Dapansutrile for Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome — Stopped early